Supporting the

Neuroendocrine Cancer Community

Scientific American: The Pandemic Is Delaying Cancer Screenings and Detection

Jan 4, 2021

The missed checkups could result in later, more severe diagnoses down the line.

After the World Health Organization declared COVID-19 a pandemic in March, the scans that Josh Mailman relies on to keep tabs on his pancreatic neuroendocrine tumors were postponed three times until July. For Mailman—who says he had considered delaying the scans even longer to reduce unnecessary hospital visits during the pandemic—the results were shocking.

Read full story here